Monday, December 28, 2020
Drugmakers Agree to Halve Prices to Secure Access to China - Bloomberg
Drugmakers Agree to Halve Prices to Secure Access to China - Bloomberg: Drugmakers from AstraZeneca Plc and GlaxoSmithKline Plc to BeiGene Ltd. agreed to cut prices on some of their newest drugs in China by an average of 51% in order to be covered by the country’s national insurance fund.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment